Novo Holdings


Novo Holdings is a leading holding and investment company responsible for managing the assets and wealth of the Novo Nordisk Foundation, one of the world’s largest enterprise foundations. The company is the controlling shareholder of Novo Nordisk and Novonesis and manages a diverse investment portfolio with a long-term return perspective. Novo Holdings invests in life science companies at all stages of development and manages a broad portfolio of equities, bonds, real estate, infrastructure assets, and private equity investments. The firm is committed to improving people’s health and the sustainability of society and the planet by generating attractive long-term returns.

Novo Holdings

Novo Holdings


Portfolio

Aquafortus develops and commercializes novel and proprietary minimal energy resource recovery technologies for high total dissolved solids (TDS) waste and process streams.

#Technology

Breye Therapeutics is a clinical stage biopharmaceutical company developing novel oral therapies for retinal vascular diseases.

#Biopharmaceutical

AnaCardio is developing novel drugs to treat heart failure, based on research from Karolinska Institutet.

#Biopharmaceutical

Clever Care helps members understand the complexities of their healthcare.

#Healthcare

Allievex is building a portfolio of therapeutics for rare pediatric neurodegenerative diseases.

#Biopharmaceutical

Coave Therapeutics is pioneering the development of innovative solutions to enhance genetic medicines.

#Genetic Medicine


Key People

Partner, Planetary Health Investments

Senior Partner, Seed Investments

Partner, Seed Investments

Senior Partner, Venture Investments

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.